Class of Stock [Axis] Total current assets Total assets Total current liabilities Total liabilities Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Total operating expenses Loss from operations Total other (expense) income, net Net loss and comprehensive loss Net loss Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash used in investing activities Net cash provided by financing activities Net increase (decrease) in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of the period Cash, cash equivalents and restricted cash at end of the period Schedule of Reconciliation of Cash and Cash Equivalents and Restricted Cash [Abstract] Total cash, cash equivalents and restricted cash Total fair value of assets Total fair value of financial liabilities Fair value, as of beginning Fair value, as of ending Fair Value Hierarchy and NAV [Axis] Total Prepaid expenses and other current assets Property and equipment, gross Property and equipment, net Property and equipment, net Total Total Other non-current liabilities Significant Agreements [Abstract] Total lease cost Schedule of Operating Leases [Abstract] Schedule of Operating Lease Liabilities Showing the Aggregate Lease Payments [Abstract] Total undiscounted lease payments Total discounted lease payments Common Stock [Abstract] Weighted Average Exercise Price, Balance Beginning Weighted Average Exercise Price, Balance Ending Award Type [Axis] Options Outstanding, Beginning balance (in Shares) Weighted Average Exercise Price, Beginning balance (in Dollars per share) Weighted Average Exercise Price, Ending Balance (in Dollars per share) Aggregate Intrinsic Value, Beginning balance Aggregate Intrinsic Value, Ending Balance Options Outstanding, Ending Balance Aggregate Intrinsic Value, Vested and expected to vest Aggregate Intrinsic Value, Vested and expected to vest, December 31, 2022 Number of Shares, Unvested restricted stock units at beginning balance Number of Shares, Unvested restricted stock at ending balance Weighted Average Grant date Fair Value, Unvested restricted stock units at beginning balance Weighted Average Grant date Fair Value, Unvested restricted stock units at ending balance Total Derivative Instrument [Axis] Statistical Measurement [Axis] Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract] Schedule of Diluted Net Loss Per Share Attributable to Common Stockholders [Abstract] Total Document Type Document Quarterly Report Document Period End Date Document Fiscal Year Focus Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line Two Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Entity Central Index Key Assets Current assets: Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Other receivables Operating lease right-of-use assets Restricted cash Other non-current assets Liabilities and Stockholders’ Equity Current liabilities: Accounts payable Current portion of operating lease liabilities Accrued expenses and other current liabilities Non-current portion of operating lease liabilities Common stock warrant liability Earnout liability Commitments and contingencies (Note XX) Stockholders’ equity Preferred stock: $0.0001 par value — XX shares authorized at March 31, 2023 and December 31, 2022; none issued and outstanding at March 31, 2023 and December 31, 2022 Preferred stock, par value (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock: $0.0001 par value — XX shares authorized at March 31, 2023 and December 31, 2022; XX and 38,045,677 shares issued and outstanding at March 31, 2023 and December 31, 2022, respectively Common stock, par value (in Dollars per share) Common stock, shares authorized Common stock, shares issued Common stock, shares issued (in Shares) Common stock, shares outstanding Additional paid-in capital Accumulated deficit Operating expenses Research and development General and administrative Interest income Other expense, net Net loss per share attributable to common stockholders, basic and diluted (in Dollars per share) Net loss per share attributable to common stockholders – basic (in Dollars per share) Net loss per share attributable to common stockholders, diluted Net loss per share attributable to common stockholders diluted Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in Shares) Weighted average shares used to compute basic net loss per share Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted Weighted average shares used to compute diluted net loss per share Issuance of common stock upon exercise of stock options Issuance of common stock upon exercise of stock options (in Shares) Number of Shares, Options exercised Performance-based stock options (in Shares) Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $6.6 million Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs of $6.6 million (in Shares) Issuance of common stock through underwritten offering, net of discounts and commissions and issuance costs Issuance of common stock through ATM offering, net of commissions and offering costs of $0.1 million Issuance of common stock through ATM offering, net of commissions and offering costs of $0.1 million (in Shares) Issuance of common stock through ATM offering, net of commissions and offering costs Reclassification of common stock warrants from liability to equity (Note 7) RSU settlements (in Shares) Vesting of founders’ restricted stock Stock-based compensation expense Issuance of common stock upon exercise of common stock warrants Issuance of common stock upon exercise of common stock warrants (in Shares) Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operating activities Depreciation and amortization expense Non-cash lease expense Stock-based compensation expense Change in fair value of common stock warrant liability Change in fair value of common stock warrant liability Changes in operating assets and liabilities: Accounts payable Accrued expenses and other current liabilities Operating lease liability Other non-current liabilities Cash flows used in investing activities Cash flows from financing activities Proceeds from issuance of common stock through ATM and underwritten offerings, net Proceeds from exercise of common stock options Cash, cash equivalents and restricted cash Supplemental and non-cash items reconciliations: Reclassification of common stock warrant liability to equity Unpaid offerings issuance costs included in accrued expenses and other current liabilities Vesting of founders’ restricted stock Right-of-use asset obtained in exchange for lease liabilities Change in fair value of earnout liability Change in fair value of earnout liability Prepaid expenses and other current assets Other receivables Other non-current assets Purchases of property and equipment Voting Common Stock, par value $0.0001 per share Redeemable Warrants, each whole warrant exercisable for one share of Voting Common Stock at an exercise price of $11.50 Common Stock Common Stock [Member] Additional Paid-In Capital Accumulated Deficit ORGANIZATION AND DESCRIPTION OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Schedule of reconciliation of cash and cash equivalents and restricted cash Cash and cash equivalents Restricted cash FAIR VALUE MEASUREMENTS Schedule of financial assets and liabilities Financial assets Money market funds Financial liabilities Earnout liability Financial assets Financial liabilities Schedule of changes in the fair value of the company’s Level 3 financial liabilities Change in the fair value included in other income (expense)